Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.78B |
| 2 |
Microsoft
MSFT
|
+$2.22B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.67B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.65B |
| 5 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$1.19B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.45B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$533M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$410M |
| 4 |
Stellantis
STLA
|
+$312M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.28% |
| 2 | Healthcare | 11.27% |
| 3 | Financials | 10.52% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 7.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3876
Willis Lease Finance
WLFC
$1.7B
| $29K | ﹤0.01% |
2,223
-1,281
| -37% | -$19.8K |
|
3877
Inovio Pharmaceuticals
INO
$55.7M
| $28.9K | ﹤0.01% |
5,393
-66,172
| -92% | -$533K |
|
3878
Workhorse Group
WKHS
$33.2M
| $28.8K | ﹤0.01% |
11
-15
| -58% | -$43.3K |
|
3879
Barclays
BCS
$92.7B
| $28.8K | ﹤0.01% |
3,665
| – | – |
|
3880
Foghorn Therapeutics
FHTX
$266M
| $28.7K | ﹤0.01% |
4,071
-6,055
| -60% | -$42.3K |
|
3881
iShares Self-Driving EV and Tech ETF
IDRV
$125M
| $28.6K | ﹤0.01% |
700
| – | – |
|
|
NYAX
3882
Nayax
NYAX
$2.55B
| $28.2K | ﹤0.01% |
1,480
+1,328
| +874% | +$24.4K |
|
3883
PDS Biotechnology
PDSB
$38.4M
| $28K | ﹤0.01% |
5,571
-33,684
| -86% | -$221K |
|
3884
LanzaTech
LNZA
$61.2M
| $28K | ﹤0.01% |
+41
| New | +$16.2K |
|
3885
HireQuest
HQI
$180M
| $27.9K | ﹤0.01% |
+1,073
| New | +$25.2K |
|
3886
ESS Tech
GWH
$22M
| $27.9K | ﹤0.01% |
1,266
-1,458
| -54% | -$26.3K |
|
3887
Atlas Lithium Corp
ATLX
$80.8M
| $27.8K | ﹤0.01% |
1,300
| – | – |
|
3888
Haleon
HLN
$43.5B
| $27.8K | ﹤0.01% |
3,317
+1,196
| +56% | +$10.2K |
|
3889
STRATTEC Security
STRT
$367M
| $27.8K | ﹤0.01% |
1,531
| – | – |
|
|
KRON
3890
DELISTED
Kronos Bio
KRON
| $27.7K | ﹤0.01% |
16,128
-23,559
| -59% | -$37.4K |
|
|
XOMA
3891
DELISTED
Xoma
XOMA
| $27.7K | ﹤0.01% |
+1,468
| New | +$27.5K |
|
3892
Lee Enterprises
LEE
$172M
| $27.6K | ﹤0.01% |
2,070
+126
| +6% | +$1.59K |
|
3893
Telecom Argentina
TEO
$6.03B
| $27.4K | ﹤0.01% |
4,500
| – | – |
|
3894
iShares Future Exponential Technologies ETF
XT
$3.82B
| $27.4K | ﹤0.01% |
492
| – | – |
|
3895
Prelude Therapeutics
PRLD
$366M
| $27.2K | ﹤0.01% |
6,052
-4,270
| -41% | -$25.5K |
|
|
NUTX
3896
Nutex Health
NUTX
$1.01B
| $27.2K | ﹤0.01% |
430
-423
| -50% | -$36.3K |
|
3897
Simulations Plus
SLP
$369M
| $27.2K | ﹤0.01% |
627
+604
| +2,626% | +$26.4K |
|
3898
Direxion Daily S&P 500 Bull 3x ETF
SPXL
$6.72B
| $27K | ﹤0.01% |
300
| – | – |
|
3899
Escalade
ESCA
$273M
| $26.9K | ﹤0.01% |
+2,015
| New | +$27.4K |
|
3900
HighPeak Energy
HPK
$903M
| $26.8K | ﹤0.01% |
2,466
-1,072
| -30% | -$18.1K |
|
Similar funds
Barclays's Q2 2023 Portfolio in Review
As of Q2 2023, Barclays held 5,371 positions worth $158B, down 28% from $218B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays withdrew a net $70.1B in Q2 2023, closing 872 positions and reducing 1,669 holdings. Its most notable exit was DCP Midstream, LP, an estimated $47.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in State Street SPDR Nuveen ICE Municipal Bond ETF worth $36.9M.
- Barclays's largest Q2 2023 buy was State Street SPDR Nuveen ICE Municipal Bond ETF: 799,988 shares worth $36.9M.
- Barclays added most to Apple in Q2 2023, an estimated $2.78B increase.
- Barclays's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.45B.
- Barclays fully exited DCP Midstream, LP in Q2 2023, selling an estimated $47.3M.
- Barclays's ten largest holdings make up 24% of its $158B portfolio in Q2 2023.
- Barclays opened 314 new positions and closed 872 in Q2 2023.
- Barclays's portfolio value fell 28% quarter-over-quarter to $158B.
Based on Barclays's 13F filing for Q2 2023, filed 3 Aug 2023.